The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?

Authors: Addeo, Raffaele; Caraglia, Michele

Source: Expert Review of Anticancer Therapy, Volume 11, Number 2, February 2011 , pp. 139-142(4)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Keywords: blood--brain barrier; brain metastasis; breast cancer; chemotherapy; lapatinib; sunitinib; tyrosine kinase inhibitor; whole-brain radiotherapy

Document Type: Research article

DOI: http://dx.doi.org/10.1586/era.10.190

Affiliations: 1: Oncology Unit, S. Giovanni di Dio Hospital, ASL Napoli 2, Nord Via Giovanni XXIII, 80027 Frattamaggiore, Naples, Italy., Email: lelloaddeo@alice.it

Publication date: 2011-02-01

More about this publication?

Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites